Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5776_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
53 Мб
Скачать
229Discussion
What is the role of radiologic methods in the evalu­ation and grading of intracranial stenoses? For decades, DSA has been the only method for direct imaging of the intracranial circulation. However, until recently, no spe­cifi c grading system has been established and stenoses were usually estimated by “eyeballing.” DSA also has technical shortcomings as it is commonly performed only in two standard levels of projection (posteroanterior and lateral). However, for MCA evaluation, the lateral image does not allow suffi cient evaluation of either the distal or proximal segments. In presumed mild to moderate stenosis, oblique and rotated views would be required, but these views are not part of the routine diagnostic algorithm in a presumed stenosis. This may be one ex­planation for the “false-positive” MCA stenoses found in TCD compared with DSA resulting in a low positive pre­dictive value of only 36% in the SONIA trial (Feldmann et al 2007). The second reason is the particular sensitivity of ultrasound within the range of mild to moderate sten­oses, as fl ow velocity is inversely related to the square of vessel diameter. Exact quantifi cation of low-grade sten- oses by DSA is diffi cult, not at least because of the small vessel diameters—2–3 mm in their main stems. Also in our case the right MCA and ACA stenoses would probably have been missed if no special attention had been paid because of the high-grade left-sided M1-MCA stenosis.
A systematic approach of using DSA for graduation of stenoses >50% was fi rst adopted in the WASID study. The stenoses were graded by using the residual and the assumed normal vessel diameters. The latter was meas­ured proximal to the stenosis within the widest visible segment. If this was not available, the next normal distal segment was used. If the complete M1-MCA or basilar ar­tery was aff ected, the distal ICA or the dominant intrac- ranial VA was used. For all intracranial ICA stenoses, the petrosal ICA segment, or if also involved, the most distal extracranial ICA diameter, were used as the reference. A 99% stenosis was diagnosed if a “gap sign,” defi ned as an absent vessel signal over a short distance, was observed. In an analysis of 24 aff ected intracranial arteries, the inter-observer agreements for the three participating readers ranged from 71% to 100% and the intra-observ­er agreements ranged from 83% to 100% (Samuels et al
2000). However, only conventional lateral and posteroan­terior images were used and patients were included only if a lumen reduction >50% was found on “eyeball” exami­nation, so low-grade stenoses were not included.
TOF-MRA and contrast-enhanced MRA are now com­monly used for assessment of the intracranial vascula­ture. TOF-MRA, based on the contrast mechanism known as fl ow-related enhancement, accentuates hemodynamic features and therefore generally overestimates the degree of stenosis, especially in cases with low fl ow distal to the ICAS. A short signal gap with preserved distal vessel seg­ments, as in our patient, is not an occlusion but corre­sponds to a high-grade stenosis. In real occlusion, there usually is a long signal gap with obviously reduced distal vessel segments or total absence of signal (Aizawa et al
2012). In unclear cases it may be helpful to analyze the source images which increase the sensitivity. Although it is “old fashioned,” even the assessment of fl ow voids on normal axial T2-weighted images may contribute to the evaluation of vessel patency. Flow appearance in
the vessel segment distal to a stenosis allows assessing its hemodynamic relevance. Reduced poststenotic ves­sel signal intensity indicates a hemodynamic relevant stenosis and also the risk of recurrent stroke (Leng et al 2013, Liebeskind et al 2014). Brightness and visibility of vessels on TOF-MRA are also related to hyperperfusion in leptomeningeal collateral activation. A prominent PCA sign in MCA steno-occlusive disorder means that the PCA serves as a collateral vessel via leptomeningeal anasto­moses (Uemura et al 2004). In acute MCA occlusion, a prominent PCA signal was referred to as the “PCA lateral­ity MRA sign” which indicated a better prognosis (Ichijo et al 2013). Almost all MRA signs mentioned were also present in our case. The mild stenoses of the right A1-ACA and M1-MCA were visible as well as the poststenotic fl ow distal to the left high-grade M1-MCA stenosis. Finally, the collateral left-sided PCA fl ow was visible as a PCA signal increase.
Contrast-enhanced MRA allows simultaneous im­aging of the entire length of the brain-supplying arter­ies, from extracranial segments to distal intracranial branches. It provides better morphologic visualization than TOF-MRA and may therefore be used especially for a high-degree stenosis with low fl ow. Its sensitivity to detect intracranial lesions is lower than that of extra­cranial lesions (van Laar et al 2006b). In the near future, 3- and 7-T MRI scanners may further contribute to bet­ter characterization of intracranial stenoses with higher accuracy and even the visualization of intracranial ves­sel wall abnormalities such as hematoma in dissection or plaque morphology like intraplaque hemorrhage, lip­id core, and fi brous cap in atherosclerosis (Bodle et al 2013, Majidi et al 2013).
Advanced multislice CTA provides excellent intrac­ranial spatial resolution and fast data acquisition times facilitating detection and graduation of intracranial sten­oses. An issue of concern to be considered in this tech­nique is radiation exposure and the intravenous contrast required. However, in hyperacute acute stroke these usually are not relevant contraindications (Klingebiel et al 2002, Saba et al 2014). If fast acquisition is required, no other technique apart from CT combines multimod­al imaging (bone, parenchyma, perfusion) rapid data acquisition (<10 seconds from aortic arch to vertex), high spatial resolution, easy vital parameter monitoring, operator independence, and high interrater agreement. Newer techniques such as volume and dual-source CT provide temporal information about blood fl ow and may further increase the utility of the CT technique. Compar­ison of CTA and TOF-MRA for the detection of intracra­nial stenoses with DSA as reference method revealed a higher sensitivity (98% versus 70%) and a higher positive predictive value (93% versus 65%) for the CTA technique. At least in selected constellations of distal BA near oc­clusion CTA was even superior to DSA, where DSA due to low fl ow phenomena or retrograde BA fl ow suggested total BA occlusion (Bash et al 2005).
The above developments require ultrasound to aim for similar diagnostic reliability and anatomic distinctive­ness, which can only be achieved using TCCS (rather than TCD) in the hands of a well-trained sonographer, which then does not compete with but rather complements the results of other diagnostic modalities.
230
Case 6
Left P2 Posterior Cerebral Artery Stenosis
Clinical Presentation
A 25-year-old woman was admitted to a district gener­al hospital with a disturbance aff ecting the right visual elds of both eyes and a right-sided hemihypesthesia. She had no history of migraine and had no other vascu­lar risk factors other than using an estrogen-containing contraceptive pill. No headaches were reported. Ischem­ic strokes of the left occipital lobe and the left thala­mus were diagnosed on MRI. No magnetic resonance angiography (MRA) was performed. Echocardiography, electrocardiogram (ECG), and transcranial Doppler (TCD) revealed normal fi ndings. Laboratory workup demonstrated mildly raised levels of lipoprotein(a) and slight hyperhomocysteinemia. Antiplatelet therapy with aspirin was started. Four weeks later, the patient was admitted to our Emergency Department because of a subjective deterioration in her right-sided visual fi elds.
Initial Neuroradiologic Findings
MRI on the day of admission showed the known posteri­or cerebral artery (PCA) infarct in the left occipital region in addition to a small area of ischemia of the left thala­mus, identical to the initial fi nding 4 weeks previously. T1-weighted images revealed a mild hyperintense signal in the region of the cortical PCA infarction, indicating a slight hemorrhagic transformation. Time-of-fl ight (TOF) MRA was suggestive of an occlusion of the left distal P2-PCA segment (Fig. B6.1 and Fig. B6.2).
Suspected Diagnosis
Hemorrhagic transformation of the known left-sided PCA infarction.
Questions to Answer by Ultrasound Techniques
• Was there an occlusion or stenosis within the left PCA?
• Was there evidence of vascular changes in the extrac­ranial brain-supplying arteries, in particular within the vertebrobasilar system?
Initial Neurosonologic Findings (Day 2)
Extracranial Duplex Sonography
Assessment of the carotid and vertebral arteries (VAs) revealed normal fi ndings. There was no evidence of a t h e r o s c l e r o s i s .
Transcranial Duplex Sonography
Normal and symmetric fl ow signals were seen in both anterior cerebral arteries (ACAs) and middle cerebral arteries (MCAs) (not shown). Flow velocities in both P1­PCA segments and the right P2-PCA segment were within the normal range. A distinct turbulent fl ow was evident in the left distal P2-PCA segment. Doppler spectrum analysis in this area revealed an increased fl ow velocity (156/75 cm/s) (Fig. B6.3, Fig. B6.4, Fig. B6.5, Fig. B6.6; see also Video
B6.1).
Conclusion
Distal left P2-PCA stenosis of unknown origin.
Clinical Course
On MRI there was no evidence of subsequent ischem­ic events. The mild hemorrhagic transformation in the PCA infarct was considered to be the cause of the clinical deterioration. Neurosonologic examination demonstrat­ed a stenosis in the distal left P2-PCA segment, which was probably overlooked during the initial TCD study 4 weeks previously. In light of the ultrasound fi ndings, the small residual MRA vessel signal in the projection of the left distal P2-PCA segment was thought to result from the weak blood fl ow distal to a high-grade steno- sis or to belong to the superior cerebellar artery. As the only known potential vascular risk factors were a mildly raised level of lipoprotein(a), a mild hyperhomocysteine­mia, and the use of an estrogen-containing contraceptive pill, an in-situ thrombus was suspected. Because of the hyperhomocysteinemia the patient was prescribed folic acid. Furthermore, we recommended that she stopped taking the combined contraceptive pill. Aspirin therapy for secondary stroke prevention was continued as no new ischemic event had occurred. Repeated clinical and ultra­sound follow-up over a 3-year period demonstrated a sta­ble neurologic status and unchanged ultrasound fi ndings.
231Clinical Course
Fig. B6.1 Left: MR FLAIR image, axial plane. Hyperintense ischem­ic lesions in the left occipital lobe as well as in the left thalamus (arrows). Right: T1-weighted image, axial plane. Mild hyperin­tense signals in the area of infarction, suggestive of hemorrhagic t r a n s f o r m a t i o n ( a r r o w s ) .
P1-PCA-R
Fig. B6.3 TCCS ( tran stemp oral a ppro ach), r ight -side d inso nation, midbrain plane. Normal fl ow in the right P1-PCA (fl ow velocity 79/37 cm/s).
P1 PCA-L
Fig. B6.2 3D TOF-MRA, axial maximal intensity projection (MIP). Absent signal of the left distal P2-PCA main stem, suggesting high­grade stenosis or occlusion (large arrow). Note the weak vessel sig­nal more distally (small arrows), probably corresponding to a PCA branch or to the superior cerebellar artery.
P2-PCA-R
Fig. B6.4 TCCS ( tran stemp oral a ppro ach), r ight -side d inso nation, midbrain plane. Normal fl ow in the right distal P2-PCA (fl ow veloc- ity 78/43 cm/s).
P2-PCA-L
Fig. B6.5 TCCS ( transte mpor al a ppro ach), left -sided i nson ation , midbrain plane. Left P1-PCA shows a normal fl ow signal (fl ow velocity 54/29 cm/s).
Fig. B6.6 TCCS ( tran stemp oral appro ach) , le ft-s ided inson atio n, midbrain plane. Intrastenotic fl ow signal in the distal left P2-PCA (fl ow velocity 156/75 cm/s).
232 Case 6 Left P2 Posterior Cerebral Artery Stenosis
Final Diagnosis
Left occipital PCA territory infarction with concomitant thalamic involvement, probably caused by an in-situ thrombus with residual left distal P2-PCA stenosis.
Discussion
Clinical Aspects
This patient is a 25-year-old woman with a left PCA in­farction probably caused by a distal P2-PCA stenosis. In view of the absence of the classic vascular risk factors, the etiology of the stenosis remained unclear.
In the United States and Europe, 5–10% of stroke pa­tients are less than 45 years of age (Jacobs et al 2002, Ma­rini et al 2001). The incidence ranges from 11.3/100,000 per year in primarily white populations to 22.8/100,000 per year in black people (Kittner et al 1993, Kristensen et al 1997). Young stroke patients more frequently have cardiac embolism associated with a patent foramen ovale (PFO). Also, a hypercoagulable state, illicit drug use, and inherited blood clotting disorders are more frequently found in young stroke patients than in the older population (Pezzini et al 2003). One of the largest population-based studies from 15 European stroke cen­ters (the 15 Cities Young Stroke Study) reported ~3,331 patients aged 15 to 49 years with fi rst-ever ischemic stroke. According to the TOAST criteria the cause of stroke remained undetermined in 39.6% of cases, 17.3% had a cardioembolism, 12.2% small-vessel disease, 9.3% large-vessel disease, and 21.6% had another determined etiology. PFO was the most frequent cardioembolic cause with a proportion of 6.6% of all strokes in this series fol­lowed by cardiomyopathy (2.0%), PFO and atrial septal aneurysm (1.8%), and ventricular wall hypo- or akinesia (1.2%). In strokes of other determined etiologies, non­atherosclerotic noninfl ammatory and infl ammatory arteriopathies, hematologic disorders, coagulopathies (genetic, acquired, or related to systemic disorders), and miscellaneous rare causes have to be mentioned. Cervi­cal artery dissection was the most common cause with
12.8% of all strokes in the series, distantly followed by antiphospholipid syndromes (1.2%), systemic vasculi­tis (0.8%), hematologic diseases (0.6%), systemic lupus erythematosus (0.5%), primary angiitis of the CNS (0.5%), migrainous infarction (0.4%), illicit drug use (0.4%), moy­amoya (0.4%), pregnancy or puerperium-related (0.3%), reversible cerebral vasoconstriction syndrome (0.2%), bromuscular dysplasia (0.2%), hyperhomocysteinemia or homocysteinuria (0.2%), CADASIL (0.2%), mitochondri­al disease (0.2%), and other rare causes like HIV-related vasculopathy in 0.1% (Putaala et al 2009, Yesilot Barlas et al 2013). For further reading on moyamoya disease, see Case 9); for cervical artery dissection, see Case 11 and Case 19; for fi bromuscular dysplasia, see Case 13; for migrainous infarction, see Case 22; for pregnancy-related and reversible cerebral vasoconstriction syndrome, see Case 36; and for HIV-related stroke, see Case 17.
CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) is
a hereditary small-vessel disease without pronounced ultrasound fi ndings but with a prolonged cerebral cir- culation time (Chabriat et al 2009, Liebetrau et al 2002). Fabr y’s disease, a lysosomal storage disease also rarely related to stroke, was not specifi ed in the 15 Cities Young Stroke Study. A separate large European multicenter trial including 5,023 patients aged 18–55 years revealed defi - nite and probable Fabry’s disease as main cause of stroke in 0.5% and 0.4%, respectively (Rolfs et al 2013). Sickle cell disease, also not specifi ed in the two European studies, is discussed in Case 43.
In our patient none of the classic vascular risk factors like arterial hypertension, diabetes mellitus, or hyper­lipidemia were present and she did not smoke. However, her homocysteine and lipoprotein(a) levels were mildly raised and she was taking an estrogen-containing contra­ceptive pill. Metabolic disorders like hyperhomocysteine­mia and homocystinuria are associated with ischemic stroke in the young population (Mineyko and Kirton 2013, Sébire et al 2004). The prevalence of mild or moderately raised homocysteine levels ranges between 10% and 20%, depending on the nutritional status of the studied popu­lation. Hyperhomocysteinemia is considered to be a risk factor for the development of atherosclerotic vessel wall changes in large arteries. A raised serum homocysteine is further associated with a two- to threefold increased risk of stroke (Bostom et al 1999, Giles et al 1998). Several consecutive studies have demonstrated that homocyste­ine levels can be lowered by 10–15% if vitamin B and folic acid supplements are taken. No benefi t of vitamin B and folic acid treatment in stroke patients with raised levels of homocysteine was reported, e.g., in the VISP (Vitamin Intervention for Stroke Prevention) study (Toole et al 2004). Also, a recent Cochrane review affi rmed that lowering hyperhomocysteinemia will not decrease a pa­tient’s cerebrovascular or cardiovascular risks for primary or secondary prevention (Martí-Carvajal et al 2015).
Lipoprotein(a) as an independent risk factor for stroke is also controversial. Some authors have report­ed higher mean lipoprotein(a) levels in stroke patients compared with controls (Pedro-Botet et al 1992). A prospective study demonstrated that the lipoprotein(a) level is an independent predictor of stroke and vascu­lar death (Ariyo et al 2003). A more recent study found that raised lipoprotein(a) levels were associated with a higher incidence of ischemic stroke. However, this was true only for white women and nonwhites of both sexes (Ohira et al 2006). Others saw increased values related with an increased hereditary risk for suff ering a vascular event. Its role as an independent stroke risk factor remains unclear (Kamstrup et al 2009). Most in­vestigations of vascular change in relation to lipopro­tein(a) have focused on the extracranial arteries. Data concerning intracranial atherosclerosis are scarce. One study reported an association with the extent of in­tracranial atherosclerotic vessel wall changes (Arenillas and Alvarez-Sabín 2005).
Female sex hormones used for contraception or for postmenopausal hormone replacement therapy in­crease the risk for vascular events including stroke. Since the fi rst reports of an association between oral contraceptives and ischemic strokes (Vessey and Doll
233Discussion
1969), a large number of studies have addressed this issue. In these studies, oral contraceptives were con­ rmed to be an independent risk factor for stroke in young women (Chan et al 2004, Gillum et al 2000, Pe­titti et al 1996, WHO 1996). However, this risk is low and is probably further lowered by the current use of low-dose estrogens and third-generation progestogens. A review of progestogen-only oral contraceptives showed no increased risk of stroke (Chakhtoura et al 2009). But the risk can increase if other risk factors such as throm­bophilia, age >30 years, smoking, hypertension, diabetes, migraine, and obesity are additionally present.
The combination of the three mentioned and dis­cussed risk factors in our patient might have contributed to the development of an intracranial atherosclerotic le­sion. However, as only one lesion was found, and because of the young age of our patient, atherosclerosis seemed unlikely and a local nonatherosclerotic vessel disease more probable.
The frequency of PCA infarctions reported by most stroke databases lies between 5% and 10% and is there­fore lower than the incidence of MCA infarctions (Brandt et al 2000). This may be one reason why there are only a few large studies on PCA infarction and its etiology, and modes of clinical presentation are less well ana­lyzed. Few clinical studies with large number of patients and detailed neurologic and cardiologic evaluation have been published (Brandt et al 2000, Steinke et al 1997, Yam am oto et a l 199 9) . In t hes e stud ies, em bol ic PCA i n­farctions occurred in 53–79% of cases. The majority of embolic events were of cardiac origin (28–41%), and to a lesser extent of artery-to-artery origin (22–32%). In-situ thrombi were seen in 8–16% of cases. Rare causes, such as coagulopathies, were found in 3–15% of cases while the cause remained unclear in up to 24% of cases. A study in a Korean population reported atherosclerotic macro­angiopathy in 42.4% of 205 patients as the most frequent cause of PCA stroke. Within this group, arterio- arterial embolism was postulated in 47.5%, perforator artery o c c l u s i o n i n 2 5 . 3 % , a n i n - s i t u t h r o m b o s i s i n 1 2 . 6 % , a n d a combination of arterio-arterial embolism and perfora­tor occlusion in 7.8%, respectively. Of the patients with a macroangiopathic cause, a pathology limited to the PCA alone was seen in 18.5%.The ventrolateral thalamus was the most frequent infarct location, followed by occipital lobe infarction in patients with isolated macroangio­pathic PCA lesions (E. Lee et al 2009). The high rate of involvement of the thalamus emphasizes that the occlu­sion of perforators at the level of the P1-PCA or proximal P2-PCA segment is a relevant stroke mechanism. In cas­es of artery-to-artery emboli, atherosclerotic vessel wall changes and dissections of the extracranial VA, followed by the intracranial VA and the basilar artery (BA), have been identifi ed as the most common embolic sources (Yamamoto et al 1999). Occasionally, atherosclerotic lesions of the internal carotid artery (ICA) can also cause PCA infarction in those individuals with a fetal-type PCA variant (Steinke et al 1997).
The high percentage of observed macroangiopathy might have been caused by the higher prevalence of in­tracranial atherosclerosis in the Asian population as well as by a better and more detailed vascular analysis of
the studied cases; however, the prevalence also seemed r e m a r k a b l e i n a w h i t e p o p u l a t i o n . I n a D a n i s h T I A p o p u ­lation a PCA stenosis 50% according to the Baumgartner criteria was found in 11% of all intracranial stenoses (von Weitzel-Mudersbach et al 2012). An even higher preva­lence of 30% was observed in an Italian study with TIA and stroke patients (Viaro et al 2012).
Besides the rarer conditions such as hypercoagulopa­thies or Sneddon’s syndrome, migraine has repeatedly been discussed as a potential cause of PCA ischemia. A migraine-associated vasospasm with secondary de­velopment of thrombi has been discussed, and its pro­portion was estimated to be as high as 10% of all PCA infarctions. One reason for this hypothesis is that PCA infarctions are accompanied by headaches in up to 50% of cases, unlike ischemic events in the anterior circula­tion (Brandt et al 2000, Pessin et al 1987). However, the most favored hypothesis at present is that PCA infarc­tions may trigger a migraine in those who are currently experiencing migraine attacks (Olesen et al 1993). Mi­graine as a basic underlying pathomechanism seems unlikely and is not supported by the available pathoan­atomic studies (Caplan 1991) (for further discussion on migraine and stroke, see Case 22).
Angiologic and Anatomic Aspects
The PCA can be subdivided into four diff erent segments from P1 to P4 (for further information, see Chapter 2, “Posterior Cerebral Artery” under “Special Arterial Anat­omy and Ultrasound Anatomy”). The pattern of PCA in­farctions follows the anatomic paths of blood supply. The P1-and proximal P2-PCA segments mainly supply the paramedian midbrain and the medial and posterolateral thalamus via small perforating arteries. Relevant cortical PCA branches start in the midpart of the P2-PCA segment with a highly variable anatomy. Usually the anterior tem­poral artery is the fi rst cortical branch followed by the occipitotemporal artery mainly supplying the middle and posterior parts of the basal temporal lobe. The following P3-PCA segment starts in the quadrigeminal cistern and quickly separates into the two main fi nal branches, the parietooccipital and calcarine arteries, which supply the mesial parietal and occipital cortex, respectively. Again, variations of vessel courses and branching are more the rule than the exception. Depending on the location of occlusion or stenosis and the capacity to develop collat­eral pathways, typical infarcts and corresponding clinical pictures appear. Embolic PCA occlusions may therefore range from total PCA infarction to a circumscribed partial cortical/subcortical ischemia. The latter frequently occurs in the calcarine artery territory as emboli generally fol­low the most direct vessel pathways. Subsequently, visual disturbance is the most common symptom, occurring in up to 90% of cases. Involvement of the thalamus indi­cates involvement of perforating arteries. In our case an involvement of the P1-PCA and/or proximal P2-PCA seg­ment was assumed. However, the stenosis detected was clearly distal to the origin of the thalamogeniculate or thalamoperforating arteries which can best be explained by a dynamic development of the vessel pathology. The rst evaluation in our clinic was performed 4 weeks after
234 Case 6 Left P2 Posterior Cerebral Artery Stenosis
the initial ischemic event. Therefore, an initial proximal occlusion, caused, for example, by an in-situ thrombus in­volving the perforator arteries, seems possible, followed by secondary partial recanalization. The observed sec­ondary hemorrhagic transformation is another positive indicator of recanalization (Molina et al 2001) possibly coinciding with the reported secondary deterioration of the patient’s visual fi eld.
Ultrasound diagnostics of the posterior intracranial circulation have considerably improved with the intro­duction of transcranial color-coded sonography (TCCS) in the early 1990s. Unlike the TCD approach, this enables the PCA, and in particular the P1-, P2-, and P3-PCA segments, to be reliably identifi ed. In our case, an initial TCD exami- nation in the fi rst admitting hospital was normal. We sus- pect that the superior cerebellar artery (SCA) signal could have been mistaken for the PCA as the two vessels are closely related and fl ow velocities and fl ow profi les are comparable (Pade et al 2010). However, even TCCS carries the risk of such confusion because of the close vicinity of both vessels (Baumgartner et al 1999). For further de­tails on insonation of the SCA, see Chapter 2, “Superior Cerebellar Artery” under “Special Arterial Anatomy and Ultrasound Anatomy.”
Despite the described advantages of TCCS, not much data exists on evaluation and quantifi cation of P2-PCA stenoses. In analogy to their evaluation of MCA stenoses, Baumgartner and coworkers (1999) described fl ow ve- locity cut-off values for determination of 50% and <50% P1- and P2-PCA stenoses. Compared with DSA results, a systolic fl ow velocity 145 cm/s yielded a sensitivity,
specifi city, and positive and negative predictive values of 100%, 100%, 100%, and 91% for the detection of a 50% PCA stenosis, respectively, and a systolic fl ow velocity 100 cm/s yielded values of 100%, 100%, 100%, and 100% for the detection of a <50% PCA stenosis, respective­ly. Another study reported cut-off values of >200 cm/s s y s t o l i c fl ow velocity for the detection of a P2-PCA stenosis (Kimura et al 2000). However, the authors used a n g l e - c o r r e c t e d v a l u e s i n a l l p a t i e n t s , i n c o n t r a s t w i t h t h e former group, which might explain the apparent diff er- ence between the two studies. An exact angle correction in intracranial vessels is often diffi cult to obtain because of the vessel elongations. Angle correction should there­fore preferentially used in the midpart of a vessel seg­ment within a straight vessel course of at least 10 mm. As this is seldom the case within the proximal course of the PCA, angle correction should not be attempted.
Scarce data are available comparing ultrasound techniques and MRA or CT angiography (CTA) for eval­uation of proximal PCA occlusions and stenoses. In an Italian study of 292 symptomatic patients, a ≥50% PCA stenosis (according to the Baumgartner criteria) was confi rmed by a second modality in approximate- ly 30% of patients with an intracranial stenosis at any site (Viaro et al 2012). Similar high rates of 30% PCA stenosis (26% and 25%, respectively) in symptomatic patients were identifi ed by CTA (Homburg et al 2011, Ovesen et al 2013). 3D TOF-MRA, however, is particu­larly prone to misinterpret low fl ow for occlusion, as could be seen in our patient, who was initially wrongly diagnosed as having a P2-PCA occlus ion.
Case 7
Cerebral Circulatory Arrest
235
Clinical Presentation
A 39-year-old woman presented with a 2-week history of progressive headache. On admission to a district general hospital, she complained of nausea, vomiting, and vertigo. She had a past medical history of malig­nant melanoma—diagnosed 3 years prior to this pres­entation—and a cerebral metastasis had been surgically removed from her right parietal lobe 1 year prior to ad­mission. Her neurologic examination revealed absent ankle jerks and bilateral positive Babinski signs. Cere­bral MRI was unremarkable—specifi cally, there were no signs of pathologic leptomeningeal enhancement. Two days after admission, she became confused and aphasic and was referred to the neurology department for fur­ther evaluation of either suspected tumor recurrence or cerebral venous thrombosis.
Initial Neuroradiologic Findings
An unenhanced cranial CT on the day of transfer showed right-sided brain swelling (Fig. B7.1). Cerebral venous thrombosis was excluded by CT angiography (not shown).
Suspected Diagnosis
Impaired consciousness of unknown etiology.
Cerebral CT
A native cerebral CT scan showed generalized brain ede­ma with small ventricles and loss of distinction between the gray and white matter (Fig. B7.2 and Fig. B7.3A). Con- trast-enhanced CT revealed a marked contrast fi lling of the M1 middle cerebral artery (MCA) segment, the M2­MCA, the A1 segment of the anterior cerebral artery (ACA) and A2-ACA, and the P1 segment of the posterior cerebral artery (PCA) and P2-PCA, indicating severely slowed cere­bral perfusion (Fig. B7.2 and Fig. B7.3B).
Question to Answer by Ultrasound Techniques
• Is there evidence of impaired perfusion of the brain­supplying arteries?
Initial Neurosonologic Findings
Extracranial Duplex Sonography
No vessel pathology was present. Doppler spectrum anal­ysis of the extracranial brain-supplying arteries ~2 hours after cerebral CT showed antegrade but severely reduced ow velocities and increased pulsatility in all vessels (not shown).
Clinical Course (1)
Meningoencephalitis or leptomeningeal carcinomatosis was suspected, but studies of cerebrospinal fl uid (CSF) did not show evidence of viral or bacterial infection. Cell dif­ferentiation was not possible due to bloody lumbar punc­ture. Paraneoplastic encephalitis was also considered, but there was no evidence of this on the cerebral MRI per­formed in the district general hospital. An EEG revealed generalized slowing of the background activity. During the next 2 days, further signs of increased intracranial pressure (ICP) became evident. Finally, she developed a severe midbrain syndrome with coma and unreactive pu­pils requiring intubation and mechanical ventilation.
Transcranial Duplex Sonography
In all detectable intracranial vessels, a bidirectional “ t o - a n d - f r o ” fl ow signal was observed (Figs. B7.4–B7.10).
Conclusion
Intracranial cerebral circulatory arrest.
Clinical Course (2)
A formal clinical diagnostic workup for the assess­ment of brain death was initiated (coma assessment, testing of brainstem refl exes). However, the patient died due to a sudden cardiac arrest before the planned apnea testing was conducted. The underlying disease
236 Case 7 Cerebral Circulatory Arrest
Fig. B7.1 Unenhanced CT, axial plane: Initial CT with predominantly right-sided mild brain swelling.
BA
Fig. B7.2 (A) Unenhanced CT, (B) postcontrast CT, corresponding parietal axial planes: Follow-up CT after clinical worsening 2 days later. Generalized brain edema with blurring of the gray–white matter junction. Note small left hemispheric spots of contrast appearing within the parenchyma: diff erential diagnosis residual parenchymal fi lling or “stasis fi lling.”
BA
Fig. B7.3 (A) Unenhanced CT, (B) postcontrast CT, correspond- ing basal axial planes: identical time point to Fig. B7.2. General­ized brain edema with blurring of gray–white matter junction at the level of the skull base. Note the contrast fi lling of the M1-MCA, M2-MCA, A1- and A2-ACA, and P1- and P2-PCA, indicating severely slowed cerebral perfusion but, according to current guidelines, not compatible with a CT-determined global cerebral circulator y arrest.
was unknown at this stage. Postmortem examination, including neuropathologic autopsy, revealed general­ized brain edema with signs of diff use leptomeninge- al melanocytosis and multiple small areas of necrosis throughout the brain.
Final Diagnosis
Generalized brain edema due to diff use leptomeningeal melanocytosis resulting in elevated ICP, cerebral circula­tory arrest, and subsequent cardiac arrest.
M1-MCA-R
Fig. B7.4 Tr an scr an ia l co lo r-c od ed d up le x so no gr aph y ( TCCS ; t ra ns ­temporal approach), right-sided insonation, midbrain plane: Right M1-MCA with bidirectional fl ow signal (fl ow velocity 122/24 cm/s).
Discussion
Clinical Aspects
In this case, a young woman died of complications from leptomeningeal melanocytosis. These complications arose from a generalized, malignant, cerebral edema-in­duced ICP elevation, which in turn, led to a cerebral cir­culatory arrest.
Leptomeningeal carcinomatosis (synonyms: neoplas­tic or carcinomatous meningitis, leptomeningeal me­tastases)—or in our case melanocytosis—is a condition
237Discussion
M1-MCA-L
Fig. B7.5 TCCS ( tran stemp oral a ppro ach), rig ht-side d inso nati on, midbrain plane: Left M1-MCA (insonation depth: 86 mm) with a bi­directional fl ow signal (fl ow velocity 64/22 cm/s).
A1-ACA-L
A1-ACA-R
Fig. B7.6 TCCS ( tran stemp oral a ppro ach), rig ht-side d inso nati on, midbrain plane: Right A1-ACA with bidirectional fl ow signal (fl ow velocity 85/18 cm/s).
P1-PCA-R
Fig. B7.7 TCCS ( tran stemp oral a ppro ach), rig ht-side d inso nati on, midbrain plane: Left A1-ACA (insonation depth 76 mm) with a bidi­rectional fl ow signal (fl ow velocity 58/19 cm/s).
P1-PCA-L
Fig. B7.9 TCCS ( tran stemp oral a ppro ach), rig ht-side d inso nati on, midbrain plane: Left P1-PCA (depth 78 mm) with a bidirectional ow signal.
Fig. B7.8 TCCS ( tran stemp oral a ppro ach), rig ht-side d inso nati on, midbrain plane: Right P1-PCA with bidirectional fl ow signal.
V4-VA-R
V4-VA-L
BA
Fig. B7.10 TCCS (transforaminal approach): Left and right V4 seg­ment of the vertebral artery (VA) and basilar artery (BA) signal with a bidirectional fl ow signal.
238 Case 7 Cerebral Circulatory Arrest
caused by diff use infi ltration of malignant cells from an extrameningeal tumor. The incidence of leptomeningeal metastases in solid tumors ranges between 4% and 15%. Improvements in diagnostic and tumor treatment strat­egies have led to an increase in the reported incidence of leptomeningeal metastases. Although all metastatic tumors can potentially infi ltrate the meninges, this is most frequently found in breast, pulmonary, and gastro­intestinal cancers. Malignant melanoma can also lead to a primary manifestation of meningeal infi ltration (Decha- phunkul et al 2011), but it generally causes a secondary leptomeningeal manifestation, which has been reported to occur in some 22–46% of cases (de la Monte et al 1983, Matsumura et al 2015).
Clinically, symptoms arise due to either (1) impaired CSF circulation or (2) direct tumor infi ltration with subsequent meningeal irritation. Symptoms usually manifest asymmetrically, which refl ects the multifocal character of the disease: 46% of patients initially pres­ent with gait disturbances and 70% have a complete loss of refl exes. Epileptic seizures, cranial nerve palsies, and radicular syndromes may also occur (Olson et al 1974, Wasserstrom et al 1982). The main symptoms associated with elevated ICP include headaches, nausea/vomiting, and personality changes. Leptomeningeosis can also imitate psychiatric disorders, thereby possibly compli­cating its diagnosis. Occasionally, the disease presents as encephalitis—including a confusion syndrome, focal neurologic defi cits, and seizures (Madow and Alpers 1951, Miller et al 1986).
The fi rst diagnostic procedures in suspected leptome- ningeal carcinomatosis should be lumbar puncture and CSF analysis. Results are frequently pathologic regardless of the presence of pathologic cells, as (1) the CSF opening pressure is elevated in >50% of cases, (2) total CSF protein elevation is found in 80% of cases, and (3) a reduction in glucose levels is found in 25–40% of cases (Posner 1995). Less than 5% of patients have normal CSF fi ndings (Reuler and Meier 1979). The diagnosis is confi rmed if malignant cells are identifi ed. As only 40–50% of cases show patho- logic cells in the initial CFS examination, repeated analy­sis is recommended with at least three lumbar punctures on three consecutive days (Glass et al 1979).
Cerebral MRI is currently approved for diagnostic morphology assessment. Gadolinium contrast-enhanced T1-weighted images detect meningeal thickening and enhancement with the highest sensitivity. However, the rate of false-negative results is >30% (Yousem et al 1990).
Our patient did not show MRI meningeal enhance­ment, which is possible at an early stage, and her CSF analysis was impaired due to repeatedly bloody lumbar punctures. When other relevant diff erential diagnoses have previously been excluded, a diagnostic meningeal biopsy might be the only remaining confi rmatory test for leptomeningeal carcinomatosis. For discussion of further treatment options, see Chamberlain (2008) and Pavlidis (2004).
Our patient fi nally developed a subsequent malignant brain edema, elevated ICP, and a cerebral circulatory arrest, which in combination with clinical testing (e.g., absence of brainstem refl exes and presence of apnea) may lead to total, irreversible loss of brain function—i.e., brain death.
Primary brain death, by defi nition, only occurs in patients treated under intensive care conditions. Otherwise, brain death is considered a sequela of cardiac death. Converse­ly, primary brain death leads to cardiac death and subse­quent loss of blood circulation. Catecholamine treatment and mechanical ventilation can stabilize a patient and prevent cessation of systemic blood circulation despite a total and irreversible loss of all brain function. Mollaret and Goulon (1959) were the fi rst to describe a group of comatose patients with loss of brainstem refl exes, apnea, and lack of EEG activity. Causes that lead to irreversible whole brain damage can either be of (1) primary origin (intracranial hemorrhage, brain infection, trauma or dif­fuse meningeal tumor like in our patient) or (2) of sec­ondary origin (cerebral hypoxia, e.g., related to temporary loss of systemic blood circulation and successful cardio­pulmonary resuscitation).
In most countries brain death is defi ned as the com- plete and irreversible loss of all brain functions. To the best of our knowledge, it is only in the UK that brain death is defi ned as a loss of brainstem function (see also Academy of the Medical Royal Colleges 2008, Smith
2015). Despite great cultural diff erences between coun- tries, donation and transplantation of organs is widely accepted and legalized by transplantation laws (Haupt and Rudolf 1999, Wijdicks 2002, 2015). Although re­gional recommendations regarding brain death criteria are heterogeneous, all guidelines maintain that the di­agnosis should be clinically based. A certain number of conditions and clinical signs have to be present—namely, (1) the total loss of brain function should be determined beyond doubt with a careful clinical examination; (2) coma; and (3) loss of all brainstem refl exes (including apnea) must be present. In most countries, two clinical confi rmatory examinations within a time interval of 2–72 hours are required. In most U.S. states, one neu­rologic examination is suffi cient; however, some U.S. state guidelines also require two examinations. Based on all guidelines, other conditions (such as intoxication, relaxation, hypothermia, metabolic or endocrine dys­functions, and shock) that may cause the above clinical ndings have to be excluded.
In Germany and Austria, two clinical examinations, or one examination in combination with a technical investi­gation to confi rm the irreversibility in loss of brain func- tion, can be performed. In the latter instance, the time interval for brain death determination can be decreased. Two main types of technical tests are available to prove the irreversibility in loss of brain function: those which document the loss of bioelectrical activity of the brain, such as EEG, acoustically evoked potentials (AEP), soma­tosensory evoked potentials (SEP), and those which doc­ument complete cessation of cerebral perfusion such as digital subtraction angiography (DSA), perfusion scintig­raphy, ultrasound, or CT angiography (CTA). Because of its simplicity and widespread availability, EEG is frequently favored. In roughly 50% of European countries, evoked brainstem potentials are approved diagnostic methods. In the United States and Canada, EEG is the only electro­physiologic test that is approved. In the second group (as­sessment of cerebral perfusion), selective four-vessel DSA is recognized to confi rm cerebral circulatory arrest. This